Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Diabetes"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
1
-
16
of
16
Search:
'"Diabetes"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who...
Published 2018
CADTH
Subjects:
“
...
Diabetes
Complications / drug therapy...
”
Read Now
3
CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Insulin glargine and lixisenatide (Soliqua -- Sanofi-Aventis Canada Inc.) : indication : adjunct to diet and exercise to improv...
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Glucagon nasal powder (Baqsimi -- Eli Lilly Canada Inc) : indication: for the treatment of severe hypoglycemia (SH) reactions w...
Published 2020
CADTH
Subjects:
“
...
Diabetes
Complications / drug therapy...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
8
CADTH CDEC final recommendation: Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Insulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.) : indication : adjunct to lifestyle modifications, for...
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Semaglutide (Ozempic -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, type 2 to improve glycemic control
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
12
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus, Type 2 / drug therapy...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
16
330 - Economics
11
Language
English
16
Collection
National Center for Biotechnology Information
16
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
10
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%22Diabetes%22&type=Subject
Send by Email
×
Loading...